Wells Fargo’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $187K | Buy |
|
|||||
|
2025
Q1 | $174K | Buy |
|
|||||
|
2024
Q4 | $161K | Buy |
|
|||||
|
2024
Q3 | $123K | Buy |
|
|||||
|
2024
Q2 | $144K | Buy |
|
|||||
|
2024
Q1 | $84.1K | Buy |
|
|||||
|
2023
Q4 | $74.7K | Buy |
|
|||||
|
2023
Q3 | $62.8K | Sell |
|
|||||
|
2023
Q2 | $410K | Buy |
|
|||||
|
2023
Q1 | $352K | Buy |
|
|||||
|
2022
Q4 | $14.7K | Sell |
|
|||||
|
2022
Q3 | $46K | Sell |
|
|||||
|
2022
Q2 | $54K | Sell |
|
|||||
|
2022
Q1 | $971K | Sell |
|
|||||
|
2021
Q4 | $1.58M | Sell |
|
|||||
|
2021
Q3 | $5.33M | Sell |
|
|||||
|
2021
Q2 | $8.95M | Buy |
|
|||||
|
2021
Q1 | $2.2M | Buy |
|
|||||
|
2020
Q4 | $1.85M | Buy |
|
|||||
|
2020
Q3 | $1.29M | Sell |
|
|||||
|
2020
Q2 | $1.63M | Sell |
|
|||||
|
2020
Q1 | $2.04M | Sell |
|
|||||
|
2019
Q4 | $5.58M | Buy |
|
|||||
|
2019
Q3 | $1.53M | Buy |
|
|||||
|
2019
Q2 | $1.5M | Sell |
|
|||||
|
2019
Q1 | $2.06M | Sell |
|
|||||
|
2018
Q4 | $23M | Buy |
|
|||||
|
2018
Q3 | $15M | Buy |
|
|||||
|
2018
Q2 | $2.5M | Buy |
|
|||||
|
2018
Q1 | $1.78M | Sell |
|
|||||
|
2017
Q4 | $2.65M | Buy |
|
|||||
|
2017
Q3 | $2.71M | Buy |
|
|||||
|
2017
Q2 | $1.17M | Sell |
|
|||||
|
2017
Q1 | $1.66M | Sell |
|
|||||
|
2016
Q4 | $1.91M | Buy |
|
|||||
|
2016
Q3 | $838K | Buy |
|
|||||
|
2016
Q2 | $551K | Buy |
|
|||||
|
2016
Q1 | $135K | Buy |
|
|||||
|
2015
Q4 | $131K | Sell |
|
|||||
|
2015
Q3 | $309K | Sell |
|
|||||
|
2015
Q2 | $423K | Sell |
|
|||||
|
2015
Q1 | $451K | Buy |
|
|||||
|
2014
Q4 | $252K | Sell |
|
|||||
|
2014
Q3 | $393K | Buy |
|
|||||
|
2014
Q2 | $446K | Sell |
|
|||||
|
2014
Q1 | $516K | Sell |
|
|||||
|
2013
Q4 | $8.22M | Sell |
|
|||||
|
2013
Q3 | $13.7M | Buy |
|
|||||
|
2013
Q2 | $4K | Buy |
|